Press Releases

Gilead Sciences to Participate in Two Upcoming Investor Conferences

- 18th Annual BIO CEO & Investor Conference -

- Leerink Partners 5th Annual Global Healthcare Conference -

- Webcasts Available Through Gilead Corporate Website -

FOSTER CITY, Calif.--(BUSINESS WIRE)--Feb. 8, 2016-- Gilead Sciences, Inc. (Nasdaq: GILD) today announced webcasts from two upcoming investor conferences: the 18th Annual BIO CEO & Investor Conference and the Leerink Partners 5th Annual Global Healthcare Conference, both taking place in New York.

John F. Milligan, PhD, Gilead’s President and Chief Operating Officer, will participate in fireside chats at the BIO CEO conference on Tuesday, February 9 at 2:00 p.m. Eastern Time (ET) and the Leerink Partners conference on Wednesday, February 10 at 8:25 a.m. ET.

The live webcasts can be accessed at the company’s Investors page at Please connect to the company’s website at least 15 minutes prior to the start of each fireside chat to ensure adequate time for any software download that may be required to listen to the webcast. The replays will be available for 14 days following each webcast.

About Gilead

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company’s mission is to advance the care of patients suffering from life-threatening diseases. Gilead has operations in more than 30 countries worldwide, with headquarters in Foster City, California.

For more information on Gilead Sciences, please visit the company’s website at, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.

Source: Gilead Sciences, Inc.

Gilead Sciences, Inc.
Patrick O’Brien, 650-522-1936
Investor Relations